The COPD 101 Library

 The COPD Foundation has expanded its excellent COPD 101 Library again. It is an excellent overview of key clinical concepts for COPD & Genetic COPD, including risk factors, epidemiology, screening and diagnostics, and treatment strategies. This presentation can be a starting point for anyone new to COPD or seeking to improve overall care. Patient education materials, created specifically to assist clear communication of disease management concepts, are also included to help optimize therapy plans.

COPD 101 is available on the site below and is in Basic PDF, Enhanced PDF (including speaker notes), and Full PowerPoint (presentation-ready) formats.  

https://www.copdfoundation.org/Learn-More/I-am-a-Healthcare-Provider/The-101-Library.aspx

Reducing Price of Inhaled Drugs

 Boehringer Ingelheim, AstraZeneca and Glaxo Smith Kline have  announced that they will begin limiting out-of-pocket costs for inhalers for eligible patients to $35/month. 

This program will start on June 1, 2024 at retail pharmacies. This price cap does not apply to government-sponsored health plans such as Medicare, Medicaid, or VA benefits.

TECHNOLOGY IS NOTHING.

'TECHNOLOGY IS NOTHING.
WHAT'S IMPORTANT IS THAT YOU HAVE A FAITH IN PEOPLE, THAT THEY-RE BASICALLY GOOD AND SMART, AND IF YOU GIVE THEM TOOLS, THEY'LL DO WONDERFUL THINGS WITH THEM.'

- STEVE JOBS